1. Home
  2. UTSI vs ENLV Comparison

UTSI vs ENLV Comparison

Compare UTSI & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTSI
  • ENLV
  • Stock Information
  • Founded
  • UTSI 1991
  • ENLV 2005
  • Country
  • UTSI China
  • ENLV Israel
  • Employees
  • UTSI N/A
  • ENLV N/A
  • Industry
  • UTSI Telecommunications Equipment
  • ENLV Biotechnology: Pharmaceutical Preparations
  • Sector
  • UTSI Telecommunications
  • ENLV Health Care
  • Exchange
  • UTSI Nasdaq
  • ENLV Nasdaq
  • Market Cap
  • UTSI 25.9M
  • ENLV 24.4M
  • IPO Year
  • UTSI 2000
  • ENLV 1995
  • Fundamental
  • Price
  • UTSI $2.65
  • ENLV $1.00
  • Analyst Decision
  • UTSI
  • ENLV Strong Buy
  • Analyst Count
  • UTSI 0
  • ENLV 2
  • Target Price
  • UTSI N/A
  • ENLV $9.50
  • AVG Volume (30 Days)
  • UTSI 5.3K
  • ENLV 50.8K
  • Earning Date
  • UTSI 03-21-2025
  • ENLV 03-28-2025
  • Dividend Yield
  • UTSI N/A
  • ENLV N/A
  • EPS Growth
  • UTSI N/A
  • ENLV N/A
  • EPS
  • UTSI N/A
  • ENLV N/A
  • Revenue
  • UTSI $14,958,000.00
  • ENLV N/A
  • Revenue This Year
  • UTSI N/A
  • ENLV N/A
  • Revenue Next Year
  • UTSI N/A
  • ENLV N/A
  • P/E Ratio
  • UTSI N/A
  • ENLV N/A
  • Revenue Growth
  • UTSI 14.41
  • ENLV N/A
  • 52 Week Low
  • UTSI $2.20
  • ENLV $0.81
  • 52 Week High
  • UTSI $3.22
  • ENLV $4.59
  • Technical
  • Relative Strength Index (RSI)
  • UTSI 48.88
  • ENLV 32.92
  • Support Level
  • UTSI $2.40
  • ENLV $1.00
  • Resistance Level
  • UTSI $2.70
  • ENLV $1.09
  • Average True Range (ATR)
  • UTSI 0.19
  • ENLV 0.08
  • MACD
  • UTSI -0.01
  • ENLV -0.00
  • Stochastic Oscillator
  • UTSI 43.33
  • ENLV 12.50

About UTSI UTStarcom Holdings Corp.

UTStarcom Holdings Corp operates as a telecom infrastructure provider. It develops technology for bandwidth from cloud-based services, mobile, streaming, and other applications. The range of solutions is designed to expand and modernize telecommunications networks through smooth network system integration, lower operating costs, and increased broadband access. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. The company operates in China, India, Japan, Taiwan and other countries.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: